One of pharmacy's most respected voices shares her thoughts on the Loblaw-Shoppers acquisition and its implications for all corners of the profession—from big and small pharmacies to suppliers to advocacy.
Canadians have one day left to let the government know how they feel about allowing a private company to pay citizens in exchange for their blood plasma, a controversial question that has health professionals divided on the safety and supply of the life-saving fluid.
What do policymakers think about pharmacies discounting their fees while at the same time lobbying them for more money? I asked two of the leaders behind Ontario’s drug reforms about the controversial practice.